Successful childbearing in two women with rheumatoid arthritis and a history of miscarriage after etanercept treatment

Two women with rheumatoid arthritis who had experienced miscarriages became pregnant while they were under etanercept treatment. One stopped etanercept after 3 weeks with increased doses of prednisolone, and the other restarted etanercept at a half doses 3 months later. They delivered a healthy baby...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Rheumatology international 2013-09, Vol.33 (9), p.2433-2435
Hauptverfasser:	Natsumi, Ikumi, Matsukawa, Yoshihiro, Miyagawa, Kohji, Kodaira, Hitomi, Tanaka, Toshitake, Horikoshi, Akira, Takeuchi, Jin, Takei, Masami, Maejima, Mamoru, Akimoto, Jun
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy Etanercept Female Humans Immunoglobulin G - therapeutic use Infant, Newborn Medicine Medicine & Public Health Miscarriage Pregnancy Pregnancy Complications - drug therapy Receptors, Tumor Necrosis Factor - therapeutic use Rheumatology Short Communication Tumor Necrosis Factor-alpha - antagonists & inhibitors Womens history
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Two women with rheumatoid arthritis who had experienced miscarriages became pregnant while they were under etanercept treatment. One stopped etanercept after 3 weeks with increased doses of prednisolone, and the other restarted etanercept at a half doses 3 months later. They delivered a healthy baby at full term, and no problems in both expecting mothers and babies were observed. The use of etanercept in patients with rheumatoid arthritis seemed safe for pregnant mothers and their fetuses.
ISSN:	0172-8172 1437-160X
DOI:	10.1007/s00296-012-2433-1